What are Merck & Co.'s total assets?

Merck & Co. (MRK) holds $128.69B in total assets, up 11.8% year over year.

How much debt does Merck & Co. have?

Merck & Co. carries $49.1B in total debt against $45.9B of shareholders' equity, a debt-to-equity ratio of 1.07.

How much cash does Merck & Co. have?

Merck & Co. holds $5.4B in cash and equivalents.

Can Merck & Co. cover its short-term obligations?

Its current ratio is 1.30 — current assets exceed current liabilities.

Where does Merck & Co.'s balance sheet data come from?

Every line is extracted from Merck & Co.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Merck & Co. MRK Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$14.69B+10.3%	$13.32B+92.8%	$6.91B-45.9%	$12.77B+56.4%
Short-term investments	$0-100%	$447M+77.4%	$252M-49.4%	$498M—
Restricted cash	$125M+64.5%	$76M+11.8%	$68M+1.5%	$67M+8.1%
Accounts receivable, net	$11.78B+14.6%	$10.28B-0.7%	$10.35B+9.5%	$9.45B+2.4%
Inventories	$5.68B+35.5%	$4.19B+25.2%	$3.35B+14.0%	$2.94B+33.9%
Finished goods	$2.28B+12.5%	$2.02B+3.5%	$1.95B+6.1%	$1.84B+5.4%
Income taxes receivable	$5.7B+46.2%	$3.9B—	——	——
Derivative assets	$323M-55.7%	$729M+113%	$342M-21.0%	$433M-21.1%
Materials and supplies	$331M+14.5%	$289M+4.3%	$277M+16.4%	$238M+21.4%
Total current assets	$43.52B+12.2%	$38.78B+20.6%	$32.17B-9.9%	$35.72B+18.0%
Property and equipment, net	$25.32B+6.5%	$23.78B+3.2%	$23.05B+7.6%	$21.42B+11.1%
Land	$321M+4.6%	$307M-5.8%	$326M+10.5%	$295M-9.5%
Buildings and improvements	$17.98B+9.9%	$16.36B+9.3%	$14.97B+13.7%	$13.17B+5.1%
Machinery and equipment	$19.76B+8.1%	$18.28B+2.9%	$17.76B+6.0%	$16.76B+2.8%
Construction in progress	$9.17B+14.8%	$7.98B-3.4%	$8.26B-10.1%	$9.19B+10.5%
Accumulated depreciation	$21.91B+14.4%	$19.16B+4.9%	$18.27B+1.6%	$17.99B-1.1%
Goodwill	$21.58B-0.4%	$21.67B+2.2%	$21.2B0.0%	$21.2B-0.3%
Deferred tax assets	$6.73B+27.8%	$5.27B+30.0%	$4.06B+34.5%	$3.02B+32.8%
Long-term investments	$956M+5.1%	$910M—	——	——
Equity securities	$1.39B+51.3%	$920M+20.4%	$764M-40.5%	$1.28B-22.0%
Total assets	$136.87B+16.9%	$117.11B+9.8%	$106.68B-2.3%	$109.16B+3.3%
Accounts payable	$4.4B+8.0%	$4.08B+4.0%	$3.92B-8.0%	$4.26B-7.5%
Dividends payable	$2.14B+2.7%	$2.08B+5.0%	$1.99B+5.4%	$1.88B+6.6%
Total current liabilities	$28.33B-0.3%	$28.42B+10.6%	$25.69B+6.0%	$24.24B+1.5%
Deferred tax liabilities	$338M-8.9%	$371M+214%	$118M-58.5%	$284M-16.0%
Long-term debt	$49.3B+32.9%	$37.1B+5.7%	$35.1B+14.3%	$30.7B-7.3%
Other non-current liabilities	$7.69B+18.9%	$6.47B-26.5%	$8.79B+5.6%	$8.32B-11.8%
Total liabilities	$324M-39.8%	$538M—	——	——
Retained earnings	$73.08B+15.9%	$63.07B+17.0%	$53.9B-11.8%	$61.08B+13.8%
Accumulated other comprehensive income (loss)	-$4.29B+13.3%	-$4.95B+4.2%	-$5.16B-8.2%	-$4.77B-7.7%
Treasury stock	$63B+8.1%	$58.3B+1.5%	$57.45B+1.7%	$56.49B-1.1%
Total stockholders' equity	$52.61B+13.6%	$46.31B+23.2%	$37.58B-18.3%	$45.99B+20.4%
Total liabilities and stockholders' equity	$136.87B+16.9%	$117.11B+9.8%	$106.68B-2.3%	$109.16B+3.3%
Allowance for Doubtful Accounts	$97M+9.0%	$89M+1.1%	$88M+22.2%	$72M+16.1%
Contract Assets, Net	$72M-14.3%	$84M-2.3%	$86M+100%	$43M-63.9%
Short- term Investments	$0-100%	$447M+77.4%	$252M-49.4%	$498M—
Other current assets	$10.52B+20.8%	$8.71B+4.0%	$8.37B+16.7%	$7.17B+2.6%
Derivative Assets - Fair Value	$323M-55.7%	$729M+113%	$342M-21.0%	$433M—
Other Inventory, Net	$72M-14.3%	$84M-2.3%	$86M+100%	$43M-63.9%
Trading Securities in Marketable Securities	$831M-3.7%	$863M+3.7%	$832M0.0%	$832M+39.6%
Accumulated Goodwill Impairment Losses	$531M0.0%	$531M0.0%	$531M0.0%	$531M0.0%
Deferred Tax Assets and Other Non-Current Assets	$1.24B+54.1%	$802M+6.2%	$755M+45.2%	$520M+19.8%
Equity Securities Without Readily Determinable Fair Value - Cumulative Downward Adjustments	$831M-3.7%	$863M+3.7%	$832M0.0%	$832M+39.6%
Equity Securities Without Readily Determinable Fair Value - Cumulative Upward Adjustments	$292M-5.5%	$309M+3.3%	$299M+3.5%	$289M+23.5%
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)	$3B+66.7%	$1.8B+28.6%	$1.4B-6.7%	$1.5B+7.1%
Indefinite-Lived Research and Development Assets	$4.13B+35.0%	$3.06B+45.9%	$2.1B+56.5%	$1.34B+389%
Intangible Assets Gross (Excluding Goodwill)	$55.41B+31.4%	$42.16B+1.3%	$41.6B-0.3%	$41.75B-1.6%
Investments - Amortized Cost Basis	$831M-3.7%	$863M+3.7%	$832M0.0%	$832M+39.6%
Net Operating Loss Carryforwards	$1.2B+31.5%	$910M+4.8%	$868M-4.8%	$912M+5.2%
Other intangible assets—net	$26.68B+63.0%	$16.37B-9.1%	$18.01B-11.1%	$20.27B-11.6%
Investments	$956M+5.1%	$910M—	——	——
Machinery and equipment	$19.76B+8.1%	$18.28B+2.9%	$17.76B+6.0%	$16.76B+2.8%
Long- term Investments	$956M+106%	$463M+83.7%	$252M-75.2%	$1.02B+174%
Other non-current assets	$18.82B+17.3%	$16.04B+33.7%	$12B+25.9%	$9.53B—
Property, plant and equipment at cost	$47.23B+10.0%	$42.93B+3.9%	$41.32B+4.8%	$39.41B+5.2%
Software and Technology Licenses, Net	$18.82B+17.3%	$16.04B+33.7%	$12B+25.9%	$9.53B—
Tax Credit Carryforward Valuation Allowance	$824M+16.1%	$710M+8.2%	$656M+9.5%	$599M+109%
Accrued Environmental Liabilities	$42M+2.4%	$41M-2.4%	$42M+7.7%	$39M-2.5%
Accrued Income Taxes, Current	$4.73B+20.7%	$3.91B+47.8%	$2.65B+33.4%	$1.99B+62.3%
Other accrued liabilities	$14.47B-7.8%	$15.69B-0.5%	$15.77B+11.3%	$14.16B+2.2%
Derivative Liabilities - Fair Value	$245M-18.1%	$299M+39.1%	$215M-2.3%	$220M+100%
Derivative Liabilities - Not Offset Policy Election Deduction	$245M-18.1%	$299M+39.1%	$215M-2.3%	$220M+100%
Lease Liability Payments - Remainder of Fiscal Year	$335M+1.8%	$329M+1.2%	$325M+0.6%	$323M-3.9%
Sales Rebates and Discounts	$1.5B-31.8%	$2.2B-4.3%	$2.3B-14.8%	$2.7B+3.8%
Debt Maturity - 2027	$2.1B+40.0%	$1.5B-31.8%	$2.2B-12.0%	$2.5B+92.3%
Deferred Tax Liabilities - Foreign Earnings	$338M-8.9%	$371M+214%	$118M—	——
Secured Borrowings Cash Right to Reclaim	$0—	$0—	$0-100%	$19M—
Unrecognized Tax Benefits	$2.53B+11.9%	$2.26B-5.2%	$2.38B+29.9%	$1.84B+20.0%
Unrecognized Tax Benefits - Impacting Effective Tax Rate	$2.5B+13.6%	$2.2B-4.3%	$2.3B+27.8%	$1.8B+20.0%
Unrecognized Tax Benefits - Income Tax Penalties and Interest Accrued	$546M+24.9%	$437M+12.6%	$388M+51.6%	$256M+33.3%
Common Stock Shares Outstanding	$275M+10.4%	$249M-43.7%	$442M-20.2%	$554M+160%
Convertible Preferred Stock Authorized Shares	20M0.0%	20M0.0%	20M0.0%	20M0.0%
Cumulative Gross Losses and Impairments	$531M0.0%	$531M0.0%	$531M0.0%	$531M0.0%
Additional paid-in capital	$45.03B+0.7%	$44.7B+0.4%	$44.51B+0.3%	$44.38B+0.3%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$1.79B0.0%	$1.79B0.0%	$1.79B0.0%	$1.79B0.0%
Number of Exercisable Options	9.3M+2.9%	9.1M-3.9%	9.5M+8.3%	8.7M-28.1%
Number of Vested and Expected to Vest Options	$272M+9.2%	$249M-43.2%	$438M-18.7%	$539M+154%
Shares Reserved for Future Issuance Under Stock Plans	66M-12.0%	75M-7.4%	81M-6.9%	87M-6.5%
Weighted Average Exercise Price of Outstanding Options	$87.95+2.2%	$86.04+11.0%	$77.54+9.9%	$70.55+8.1%
Weighted Average Exercise Price of Vested and Expected to Vest Options	$87.73+3.1%	$85.10+11.1%	$76.63+9.3%	$70.09+8.0%
Aggregate Notional Principal Outstanding	$40.29B+4.5%	$38.56B+26.2%	$30.55B+6.5%	$28.68B-13.0%
AOCI - Cash Flow Hedge Reclassification (Next 12 Months)	-$178M-168%	$262M+755%	-$40M—	——
Gross Assets/Liabilities	$324M-6.1%	$345M+44.4%	$239M-41.6%	$409M+238%
Long-term debt interest payments - 2024	$1.7B+54.5%	$1.1B0.0%	$1.1B+41.4%	$778M-7.2%
Long-term debt interest payments - 2025	$1.6B+45.5%	$1.1B+10.0%	$1B+33.2%	$751M-2.6%
Long-term debt interest payments - 2026	$1.5B+50.0%	$1B0.0%	$1B+38.9%	$720M-3.1%
Accrual for Environmental Loss Contingencies	$42M+2.4%	$41M-2.4%	$42M+7.7%	$39M-2.5%
Allowance for doubtful accounts	$97M+9.0%	$89M+1.1%	$88M+22.2%	$72M+16.1%
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	$0—	$0—	$0—	$0—
Gross Unrealized Gains	$0—	$0—	$0—	$0—
Total	$101M-81.2%	$536M+59.1%	$337M-40.8%	$569M+562%
Available for sale investments	$101M-81.2%	$536M+59.1%	$337M-40.8%	$569M+562%
Common stock, par value (in dollars per share)	$0.500.0%	$0.500.0%	$0.500.0%	$0.500.0%
Common stock, shares authorized (in shares)	6.5B0.0%	6.5B0.0%	6.5B0.0%	6.5B0.0%
Common stock, shares issued (in shares)	3.6B0.0%	3.6B0.0%	3.6B0.0%	3.6B0.0%
Construction work in progress	$9.17B+14.8%	$7.98B-3.4%	$8.26B-10.1%	$9.19B+10.5%
Short-term debt and current portion of long-term debt	$2.59B-2.3%	$2.65B+93.1%	$1.37B-29.5%	$1.95B-19.3%
Debt Instrument, Fair Value Disclosure	$45.6B+39.9%	$32.6B+1.9%	$32B+19.9%	$26.7B-25.2%
Debt Securities and Equity Securities, FV-NI	$1.49B+2.5%	$1.46B+32.2%	$1.1B-40.6%	$1.85B+6.9%
Deferred Tax Liabilities, Gross	$5.57B+82.2%	$3.06B+3.3%	$2.96B-31.3%	$4.31B-14.2%
Deferred income taxes	$1.44B+3.7%	$1.39B+59.2%	$871M-51.5%	$1.8B-47.8%
Deferred Tax Assets, Goodwill and Intangible Assets	$140M+97.2%	$71M—	$0—	$0—
Deferred Tax Assets, Gross	$7.56B+26.4%	$5.98B+26.9%	$4.71B+30.4%	$3.61B+41.3%
Deferred Tax Assets, Net	$1.17B-47.3%	$2.21B+102%	$1.1B—	——
Deferred Tax Assets, Net of Valuation Allowance	$6.73B+27.8%	$5.27B+30.0%	$4.06B+34.5%	$3.02B+32.8%
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits	$117M-47.8%	$224M-30.7%	$323M-13.2%	$372M-23.6%
Deferred Tax Assets, Valuation Allowance	$824M+16.1%	$710M+8.2%	$656M+9.5%	$599M+109%
Federal and state intangible assets	$3.27B+235%	$978M-25.2%	$1.31B-49.2%	$2.58B-19.7%
Deferred Tax Liabilities, Other	$134M-15.7%	$159M-25.7%	$214M-19.9%	$267M+48.3%
Deferred Tax Liabilities, Property, Plant and Equipment	$594M-7.9%	$645M+3.0%	$626M-6.0%	$666M+13.1%
Derivative Asset, Subject to Master Netting Arrangement, after Offset	$77M-70.9%	$265M+114%	$124M-15.6%	$147M—
Potential reduction in net position of total derivative assets	$245M—	——	——	——
Margin cash collateral received from counterparties that was not offset against derivative assets	$1M—	——	——	——
Margin cash collateral provided to counterparties that was not offset against derivative assets or liabilities	$0—	——	——	——
Derivative, gross, assets	$323M-55.7%	$729M+113%	$342M-21.0%	$433M—
Derivatives, gross, liabilities	$324M-6.1%	$345M+44.4%	$239M-41.6%	$409M—
Derivative Liability	$324M-6.1%	$345M+44.4%	$239M-41.6%	$409M+238%
Derivative Liability, Subject to Master Netting Arrangement, after Offset	$79M+71.7%	$46M+91.7%	$24M-85.9%	$170M—
Potential reduction in net position of total derivative liabilities	$245M-18.1%	$299M+39.1%	$215M-2.3%	$220M+100%
Notional	$40.29B+4.5%	$38.56B+26.2%	$30.55B+6.5%	$28.68B-13.0%
Trading securities, cost	$831M-3.7%	$863M+3.7%	$832M0.0%	$832M+39.6%
Finite-Lived Intangible Assets, Accumulated Amortization	$28.73B+11.4%	$25.79B+9.3%	$23.59B+9.8%	$21.48B+10.1%
2028	$3.6B+56.5%	$2.3B+35.3%	$1.7B0.0%	$1.7B+6.3%
2030	$3B+66.7%	$1.8B+28.6%	$1.4B-6.7%	$1.5B+7.1%
2031	$2.7B+80.0%	$1.5B+36.4%	$1.1B-15.4%	$1.3B-7.1%
2027	$3.8B+58.3%	$2.4B+33.3%	$1.8B0.0%	$1.8B+5.9%
2029	$3.3B+57.1%	$2.1B+31.3%	$1.6B0.0%	$1.6B0.0%
Goodwill accumulated impairment losses	$531M0.0%	$531M0.0%	$531M0.0%	$531M0.0%
Carrying values of hedged liabilities	$1.81B—	——	——	——
Cumulative amount of fair value hedging adjustment	$70M—	——	——	——
Indefinite- lived intangible impairment	$55.41B+31.4%	$42.16B+1.3%	$41.6B-0.3%	$41.75B-1.6%
Inventory, LIFO Reserve	$912M—	——	——	——
Inventory Net And Inventory Noncurrent	$12.34B+19.8%	$10.3B+6.1%	$9.71B+9.7%	$8.85B+8.6%
Raw materials and work in process	$10.65B+20.5%	$8.83B+9.9%	$8.04B+13.8%	$7.06B—
Committed Revolving Credit Facilities	$6B0.0%	$6B0.0%	$6B0.0%	$6B0.0%
2028	$2.7B+22.7%	$2.2B-12.0%	$2.5B+92.3%	$1.3B-23.5%
2029	$2.1B+40.0%	$1.5B-31.8%	$2.2B-12.0%	$2.5B+92.3%
2029	$2.7B+58.8%	$1.7B-19.0%	$2.1B+40.0%	$1.5B-34.8%
2030	$3B+42.9%	$2.1B+40.0%	$1.5B-31.8%	$2.2B-12.0%
2027	$2.6B0.0%	$2.6B+85.7%	$1.4B-17.6%	$1.7B-26.1%
Noncontrolling interests in subsidiaries	$56M-5.1%	$59M+9.3%	$54M-19.4%	$67M-8.2%
Other financial assets	$537M-1.6%	$546M—	——	——
Preferred Stock, Shares Authorized	$20M0.0%	$20M0.0%	$20M0.0%	$20M0.0%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price	$87.73+3.1%	$85.1+11.1%	$76.63+9.3%	$70.09+8.0%
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number	$9.35M+2.9%	$9.08M-3.9%	$9.45M+8.3%	$8.73M-28.1%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	$12.48M-0.2%	$12.5M-7.6%	$13.53M-1.4%	$13.72M-26.1%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	$12.24M+0.3%	$12.2M-7.0%	$13.12M-0.6%	$13.2M-26.0%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value	$272M+9.2%	$249M-43.2%	$438M-18.7%	$539M+154%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$87.95+2.2%	$86.04+11.0%	$77.54+9.9%	$70.55+8.1%
Incentive stock program, shares reserved for future grants (in shares)	$66M-12.0%	$75M-7.4%	$81M-6.9%	$87M-6.5%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value	$275M+10.4%	$249M-43.7%	$442M-20.2%	$554M+160%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$82.09+10.9%	$74+7.3%	$68.97+5.7%	$65.24+8.0%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value	$244M+1.2%	$241M-36.4%	$379M-5.0%	$399M+102%
Stockholders' Equity before Treasury Stock	$115.61B+10.5%	$104.62B+10.1%	$95.03B-7.3%	$102.48B+7.5%
Tax Cuts and Jobs Act payment	$1.2B—	——	——	——
Treasury stock, shares (in shares)	1.1B+5.1%	1B+0.4%	1B+0.6%	1B-1.0%
Unrecognized tax benefits	$2.53B+11.9%	$2.26B-5.2%	$2.38B+29.9%	$1.84B+20.0%
Penalties and interest accrued on unrecognized tax benefits	$546M+24.9%	$437M+12.6%	$388M+51.6%	$256M+33.3%
Amount that if recognized, would affect the effective tax rate or regulatory liability	$2.5B+13.6%	$2.2B-4.3%	$2.3B+27.8%	$1.8B+20.0%
Unrecorded Unconditional Purchase Obligation	$400M+119%	$183M—	——	——
Unrecorded Unconditional Purchase Obligation	$400M+119%	$183M—	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Merck & Co..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Merck & Co.'s total assets?: Merck & Co. (MRK) holds $128.69B in total assets, up 11.8% year over year.
How much debt does Merck & Co. have?: Merck & Co. carries $49.1B in total debt against $45.9B of shareholders' equity, a debt-to-equity ratio of 1.07.
How much cash does Merck & Co. have?: Merck & Co. holds $5.4B in cash and equivalents.
Can Merck & Co. cover its short-term obligations?: Its current ratio is 1.30 — current assets exceed current liabilities.
Where does Merck & Co.'s balance sheet data come from?: Every line is extracted from Merck & Co.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.